| IPO Company Profile © ipodata.com |
| Message Board | SEC Filings | Peer IPO Companies |
| iPhysician Net, Inc. |
| 8777 north Gainey Center Drive, Suite 285, Scottsdale, AZ 85258 * (480) 368-2768 |
| Business Description | The company is an application service provider who uses the Internet and high-speed telecommunications to enhance the efficiency, quality and convenience of communications between pharmaceutical companies and physicians. |
|
Filing Information IPO has been | |||
| To Trade As | IPNI (NASNTL) | Industry | Internet (SIC 7389) |
| Type of Stock Offered | Common Shares | Filing Date | 2/4/00 |
| Domestic Shares Filed | 0 | Filing Price | - - |
| Foreign Shares Filed | 0 | Offering Amount | $55,000,000 |
| Company Shares | 0 | Est. Expenses | - - |
| Selling Shrhldrs Shares | 0 | Post-IPO Shares | - - |
| Primary Underwriting Group | ||
| Underwriter Name | Participation | Underwriter Phone |
| Lehman Brothers Incorporated | Lead Manager | (212) 526-8100 |
| Prudential Volpe Technology | Co-manager | (415) 274-4463 |
| WR Hambrecht & Co | Co-manager | (415) 551-8600 |
| Income Statement and Cash Flow Summary | |||||||
| Prior Audited Income |
Latest Unaudited Income | ||||||
| Full Year Audited Figures | 9 Months Ending | ||||||
| Figures in U.S. millions except per share data | 12/31/96 | 12/31/97 | 12/31/98 | 9/30/98 | 9/30/99 | ||
| Revenues | - | - | 0.000 | 0.000 | 0.924 | 0.550 | 0.399 |
| Income from Oper. | - | - | -0.645 | -1.051 | -4.813 | -3.370 | -5.435 |
| Net Income | - | - | -0.645 | -1.094 | -4.834 | -3.385 | -5.895 |
| E.P.S | - | - | -0.440 | -0.490 | -0.830 | - | -1.400 |
| Revenue Growth (%) | - | - | - | - | -27.45 | ||
| Net Income Growth (%) | - | - | - | - | - | ||
| Oper. Profit Margin (%) | - | - | - | - | - | - | - |
| Net Profit Margin (%) | - | - | - | - | - | - | - |
| Cash Flow - Oper. | -2.97 | - | - | ||||
| Cash Flow - Inv. | -0.34 | - | - | ||||
| Cash Flow - Fin. | 4.58 | - | - | ||||
| Balance Sheet Summary and Financial Ratios | |||||
| Balance sheet as of: 9/30/99 | Financial Ratios | ||||
| Total Assets | 13.03 | Current Assets | - | Current Ratio | - |
| Total Liab. | 3.22 | Current Liab. | - | Debt Ratio | 24.69% |
| Total Equity | 9.81 | Working Cap. | 9.20 | Debt to Equity Ratio | 0.33 |
| Cash | 11.52 | Return on Assets | - | ||
| Use Of Proceeds |
The proceeds from the proposed offering will be used for general corporate purposes including funding our application service introductions, and other working capital needs. |
| Legal Counsel Registrar Auditor | |
| Issuer's Law Firm | Snell & Wilmer |
| Bank's Law Firm | Bingham, Dana & Gould |
| Auditor | KPMG LLC |
| Send us feedback if you would like to request that we hyperlink a firm on this page | |
| Principal Shareholders | ||
| Name of Shareholder | % Owned Before | % Owned After |
| Veron International Limited | 29.80 | |
| Entities affiliated with BioAsia Investments | 20.30 | |
| Sentron Medical, Inc. | 13.30 | |
| Entities affiliated with MDS Life Sciences Technology Fund | 13.30 | |
| PictureTel Corporation | 9.00 | |
| Note: represents ownership of 5% or more prior to the offering. | ||